RESUMO
Pulmonary angiosarcoma (PAS) is a malignant tumor of the vascular wall of mesenchymal origin. PAS is rare and has unknown etiology and poor prognosis. Depending on the location, angiosarcoma can lead to serious obstructive and embolic complications, as well as severe pulmonary hypertension and right ventricular heart failure. Patients with PAS are often mistakenly diagnosed with pulmonary embolism, chronic thromboembolic pulmonary hypertension, or lung tumors. Here, we present a clinical case of combined treatment of PAS.
Assuntos
Hemangiossarcoma , Hipertensão Pulmonar , Embolia Pulmonar , Doença Crônica , Endarterectomia , Hemangiossarcoma/complicações , Hemangiossarcoma/diagnóstico , Hemangiossarcoma/cirurgia , Humanos , Hipertensão Pulmonar/etiologiaRESUMO
BACKGROUND: The use of dual continuous-flow assist devices for biventricular support remains novel with only small case series or reports documenting outcomes. METHODS: We describe a 21-year-old woman suffered stabbing with damage of coronary artery with subsequent myocardial infarction and severe postinfarction heart failure with impaired right ventricular function. The patient underwent implantation of two continuous-flow ventricular assist devices. RESULTS: The early postoperative period was followed by severe respiratory insufficiency and an asthenic syndrome, which required prolonged intensive care and mechanical ventilation. After prolonged hospital stay, she was discharged home waiting for heart transplantation. CONCLUSIONS: With the continuing miniaturization of pump designs, less invasive, more durable and cost-effective pumps have become available for dual assist device therapy in in these critically ill heart failure patients.